Search

everythinglearnresearchcommunity

for

Search:↓

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

TSH is usually the only test needed to check thyroid function in primary care.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

New treatments for male hypogonadism are effective and should be personalized.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Sabal and Urtica extract works as well as finasteride for treating BPH, with fewer side effects.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Doctors need to be better prepared to assess and treat obesity in patients.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Laser hair removal improves quality of life but emotional benefits decrease over time, suggesting more treatments are needed for lasting effects.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.